Yayınlar & Eserler

Yayın Ağı
Makaleler 92
Tümü (92)
SCI-E, SSCI, AHCI (74)
SCI-E, SSCI, AHCI, ESCI (84)
ESCI (10)
Scopus (84)
TRDizin (20)

1. Effects of Curcumin on Cancer Stem Cell Markers and P-Glycoprotein-Mediated Drug Resistance in U87 Glioblastoma Cells

NAZLIGÜL E., ÖZERMAN EDİS B., YENEREL M. N., GÜNÇER B.
Sabiad , cilt.8, sa.3, ss.137-148, 2025 (Hakemli Dergi) Sürdürülebilir Kalkınma

2. Therapeutic Challenges and Emerging Strategies for T674I and PTPN11 Mutations in a FIP1L1-PDGFRA-Positive Myeloproliferative Neoplasm: A Case Report

Özkan S. G., Kimiaei A., Safaei S., Karkucak M., Yenerel M. N., Öztürkmen A. Y., et al.
Life , cilt.15, sa.3, 2025 (SCI-Expanded) identifier identifier

3. Impact of COVID-19 on Hematologic Disorders: Clinical Insights and Challenges

ERDEM S., SERT EKİNCİ S., ÖZBALAK M. M., MASTANZADE M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Istanbul Medical Journal , cilt.26, 2025 (ESCI)

4. Akut Miyeloid Lösemi’li Olgularda inv(3)/t(3;3) ile 7.Kromozomun Anomalilerinin Prognoza Etkisi

BAYRAK TOKAÇ A. G., BAĞATIR G., ERDEM S., ÇEFLE K., ÖZTÜRK Ş., YENEREL M. N., et al.
Manisa Celal Bayar Üniversitesi Eğitim Fakültesi Dergisi , cilt.11, ss.334-339, 2024 (Hakemli Dergi) identifier

5. Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey.

Kıkılı C. İ., Kıvanç D., Ortaboz D., Şentürk Çiftçi H., Özbalak M. M., Yenerel M. N., et al.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis , cilt.35, sa.6, ss.307-315, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

6. Immunosuppression-Based Lymphoproliferative Disease Features and Parameters Affecting Survival

Göktaş Aydın S., Nalçacı M., Yönal Hindilerden İ., Beşışık S., Yenerel M. N.
Genel Tıp Dergisi , cilt.34, sa.5, ss.671-679, 2024 (Hakemli Dergi)

7. INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION

AMIKISHIYEV S., BEŞIŞIK S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., ÇAĞATAY A. A., ERDEM S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.87, sa.3, ss.246-252, 2024 (ESCI) identifier identifier

8. Expression Patterns of Eighteen Genes Involved in Crucial Cellular Processes in the TP53 Pathway in Multiple Myeloma

Öztan G., Suer İ., Aday A., Ayer M., Öztürk Ş., Çefle K., et al.
GAZI UNIVERSITY JOURNAL OF SCIENCE , cilt.37, sa.3, ss.1066-1082, 2024 (ESCI) Sürdürülebilir Kalkınma identifier identifier

9. CLL-079 The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)

Seyithanoglu D., Nazligul E., Ozbalak M. M., Mastanzade M., Erdem S., Nalcaci M., et al.
CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA , cilt.23, ss.319-320, 2023 (SCI-Expanded) Creative Commons License identifier

10. The Effect of T-Lymphocyte Subgroups at Diagnosis on the Prognosis of Chronic Lymphocytic Leukemia (CLL)

Seyithanoglu D., Nazligul E., ÖZBALAK M. M., MASTANZADE M., ERDEM S., NALÇACI M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023 (SCI-Expanded) identifier

11. Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey

Dal M. S., Ulu B. U., UZAY A., Akay O. M., Besisik S., Yenerel M. N., et al.
ANNALS OF HEMATOLOGY , cilt.102, sa.1, ss.133-140, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

12. Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up

Yenerel M. N., de Fontbrune F. S., Piatek C., ŞAHİN F., Fuereder W., Ortiz S., et al.
ADVANCES IN THERAPY , cilt.40, sa.1, ss.211-232, 2023 (SCI-Expanded) Creative Commons License identifier identifier identifier

13. Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen

Hindilerden F., Yonal-Hindilerden I., Yenerel M. N., Nalcaci M., Diz-Kucukkaya R.
Hematology Reports , cilt.14, sa.3, ss.222-227, 2022 (ESCI) Creative Commons License identifier identifier

14. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia

Erkek E. T., Nazligul E., Nalcaci M., Yenerel M. N.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.38, sa.2, ss.319-326, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

15. Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Özbalak M. M., Güzel Mastanzade M., Özlük Ö., Tiryaki T. O., Erdem S., Özbalak E. P., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.39, sa.4, ss.254-261, 2022 (SCI-Expanded) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier identifier

16. Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A., Furman R. R., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.31, ss.3441-3454, 2021 (SCI-Expanded) identifier identifier identifier

17. Raman tweezers as an alternative diagnostic tool for paroxysmal nocturnal hemoglobinuria.

Soysal K. B., Parlatan S., Mastanzade M., Ozbalak M. M., Yenerel M. N., ÜNLÜ M. B., et al.
Analytical methods : advancing methods and applications , cilt.13, sa.35, ss.3963-3969, 2021 (SCI-Expanded) identifier identifier identifier

18. R-CHOP Chemotherapy with a Rituximab Biosimilar (Redditux®) for Patients with de novo Diffuse Large B-cell Lymphoma: First Preliminary Results of a Real-Life Single-Center Experience from Turkey

Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Pınar Özbalak E., Yönal Hindilerden İ., et al.
İstanbul Kanuni Sultan Süleyman Tıp Dergisi , cilt.13, sa.3, ss.194-198, 2021 (Hakemli Dergi)

19. First Results of a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia

Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A., Furman R. R., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.21, 2021 (SCI-Expanded) identifier

20. First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.

Byrd J. C., Hillmen P., Ghia P., Kater A. P., Chanan-Khan A. A. A., Furman R. R., et al.
JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.15, 2021 (SCI-Expanded) identifier

21. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis

KEKLİK KARADAĞ F., Yenerel M. N., YILMAZ M., ÜSKÜDAR TEKE H., ÖZKOCAMAN V., Tuglular T. F., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.11, sa.3, ss.279-285, 2021 (ESCI) identifier

22. Unusual Presentations of LMNA-Associated Lipodystrophy with Complex Phenotypes and Generalized Fat Loss: When the Genetic Diagnosis Uncovers Novel Features

de Andrade N. X. S., Adiyaman S. C., De Yuksel B., Ferrari C. T., Eldin A. J., Saydam B. O., et al.
AACE Clinical Case Reports , cilt.6, sa.2, 2020 (Scopus) Creative Commons License identifier

23. Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia

Ozdemir Z. N., İLHAN O., Ozet G., Falay M., Yenerel M. N., Tuglular T., et al.
CLINICAL LABORATORY , cilt.66, sa.9, ss.1709-1715, 2020 (SCI-Expanded) identifier identifier identifier

24. Retrospective Analysis of Peripheral T-Cell Lymphoma Patients: Single Center 'Real-Life' Experience

Ozbalak M. M., MASTANZADE M., Ozluk O., TİRYAKİ T. O., Hindilerden I. Y., YENEREL M. N., et al.
MEDICAL JOURNAL OF BAKIRKOY , cilt.16, sa.4, ss.392-398, 2020 (ESCI) Creative Commons License identifier

25. Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients

Ilhan O., Ozdemir Z. N., Ozet G., Falay M., Yenerel M. N., Tuglular T., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.58, sa.5, ss.659-662, 2019 (SCI-Expanded) identifier identifier identifier

26. Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis

Sariman M., Abaci N., Ekmekci S., Cakiris A., Pacal F., Ustek D., et al.
Balkan medical journal , cilt.36, sa.1, ss.23-31, 2019 (SCI-Expanded) identifier identifier identifier

27. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., Ozkocaman V., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded) identifier identifier identifier

28. Investigation of ErbB and Insulin Signaling Pathways in the Pathogenesis of Multiple Myeloma

Ozturk D., Coskunpinar E. M., Osmanbasoglu E., ÇETİN G., Yenerel M. N., Ayer M., et al.
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI , cilt.56, sa.2, ss.109-113, 2018 (ESCI) identifier identifier

29. Dramatic Reduction of LATS2 Tumor Suppressor Protein Expression in Patients with CLL: Evaluation of LATS2 Levels with Clinical Features and Immunophenotypic Profile

Sert E., Coskunpinar E., Yenerel M. N., Aktan M., Ozturk D., Ozturk O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.28, sa.3, ss.137-146, 2018 (SCI-Expanded) identifier identifier

30. Clinical course and disease burden in patients with paroxysmal nocturnal hemoglobinuria by hemolytic status

Yenerel M. N., Muus P., Wilson A., Szer J.
BLOOD CELLS MOLECULES AND DISEASES , cilt.65, ss.29-34, 2017 (SCI-Expanded) identifier identifier identifier

31. Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases

Hindilerden F., Yonal-Hindilerden I., Yenerel M. N., Nalcaci M., Diz-Kucukkaya R.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.72-80, 2017 (SCI-Expanded) identifier identifier identifier

32. The frequency of C609T polymorphism in the NQO1 gene and its relation to cytogenetic abnormalities in patients with myelodysplastic syndrome.

Bagatır G., Sırma S. Ö., Palanduz S., Ozturk Ş., Cefle K., Ozbek U., et al.
Cellular and molecular biology (Noisy-le-Grand, France) , cilt.62, sa.7, ss.61-5, 2016 (SCI-Expanded) identifier identifier identifier

33. Pesg PNH diagnosis, follow-up and treatment guidelines

ŞAHİN F., Akay O. M., Ayer M., Dal M. S., Ertop S., İLHAN O., et al.
AMERICAN JOURNAL OF BLOOD RESEARCH , cilt.6, sa.2, ss.19-27, 2016 (ESCI) identifier

34. Acquired FVIII and FIX Inhibitors after Pregnancy: A Case Report.

Kose M., Bakkaloglu O. K., Amikishiyev S., Akpinar T. S., Saracoglu B., Akcan T., et al.
Acta haematologica , cilt.136, sa.4, ss.229-232, 2016 (SCI-Expanded) identifier identifier identifier

35. The Importance of Eculizumab in Patients with Atypical Hemolytic Uremic Syndrome: Single Center Experience

Yenerel M. N., Aktan M., Yildiz A., Caliskan Y., Nalcaci M.
BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded) identifier

36. Atypical Hemolytic Uremic Syndrome: Differential Diagnosis from TTP/HUS and Management

Yenerel M. N.
TURKISH JOURNAL OF HEMATOLOGY , cilt.31, sa.3, ss.216-225, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

37. Leukemic ascites as an initial presentation of acute myelomonocytic leukemia with inversion of chromosome 16.

Yonal I., Kayar Y., Nazligul E., Yenerel M. N., Kalayoglu-Besisik S.
Annals of Saudi medicine , cilt.33, sa.2, ss.197-8, 2013 (SCI-Expanded) identifier identifier identifier

38. Massive ascites as the initial manifestation of mantle cell lymphoma: A challenge for the gastroenterologist

Yonal I., Ciftcibasi A., Gokturk S., Yenerel M. N., Akyuz F., Karaca C., et al.
Case Reports in Gastroenterology , cilt.6, sa.3, ss.803-809, 2012 (Scopus) identifier identifier

39. Analysis of p53 Tumor Suppressor Pathway Genes in Chronic Lymphocytic Leukemia

Isin M., Yenerel M. N., Aktan M., Buyru N., Dalay N.
DNA AND CELL BIOLOGY , cilt.31, sa.5, ss.777-782, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

40. A case of chronic lymphocytic leukemia with massive ascites

Yonal I., Nazligul E., Tas G., Agan M. R., YENEREL M. N., NALÇACI M.
RARE TUMORS , cilt.4, sa.4, ss.165-168, 2012 (ESCI) identifier identifier identifier

41. Unusual presentation of adrenal lymphoma observed with PET-CT

Ozkan Z. G., Turkmen C., Sanli Y., Yenerel M. N., Adalet I.
TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.4, ss.337-338, 2011 (SCI-Expanded) identifier identifier identifier

42. A case of thrombotic thrombocytopenic purpura due to clopidogrel: Case report

Kayacan S. M., Vatansever S., YENEREL M. N., Akkaya V., Kayacan D., Erk O., et al.
Turkiye Klinikleri Cardiovascular Sciences , cilt.22, sa.2, ss.270-272, 2010 (Scopus) identifier

43. NILOTINIB EFFICACY IN 21 IMATINIB-RESISTANT OR-INTOLERANT T (9;22) POSITIVE CHRONIC MYELOID LEUKEMIA PATIENTS WITH AND WITHOUT ADDITIONAL CHROMOSOMAL CHANGES

Yavuz A. S., Elcioglu O. C., Akpinar T. S., Cosan F., Ucur A., Bayrak A., et al.
NOBEL MEDICUS , cilt.6, sa.2, ss.57-62, 2010 (SCI-Expanded) identifier identifier

44. Peritoneal seeding and subsequent progression of mantle cell lymphoma after splenectomy for debulking

Bahat G., Saka B., Yenerel M. N., Yilmaz E., Tascioglu C., Dogan O.
CURRENT ONCOLOGY , sa.3, ss.78-82, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

45. Hyperbaric oxygen: An important treatment modality in severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

Yenerel M. N., Kalayoglu-Besisik S., Perdeci O., Gurses N., Tunc M., Sargin D.
Turkish Journal of Hematology , cilt.26, sa.4, ss.176-180, 2009 (SCI-Expanded) identifier identifier identifier

46. 2nd international congress on leukemia, lymphoma and myeloma

Arat M., Özsan G. H., Yenerel M. N., Cetin M., ÖZCAN M.
Expert Review of Hematology , cilt.2, sa.5, ss.509-512, 2009 (Scopus) identifier identifier

47. Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia

Palanduz S., Bayrak A., Sirma S., Vural B., Cefle K., Ucur A., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS , cilt.13, sa.5, ss.599-602, 2009 (SCI-Expanded) identifier identifier identifier

48. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.

Sayitoglu M., Haznedaroğlu İ. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.
The Journal of international medical research , cilt.37, sa.4, ss.1018-28, 2009 (SCI-Expanded) identifier identifier identifier

49. PRESENTING CLINICAL AND LABORATORY FINDINGS OF 282 PATIENTS WITH HODGKIN'S DISEASE

Sahinoglu S., Yenerel M. N., Guvenc S., Kucukkaya R. D., Nalcaci M.
NOBEL MEDICUS , cilt.5, sa.2, ss.18-23, 2009 (SCI-Expanded) identifier identifier

50. Sheehan's Syndrome Associated with Glanzmann's Thrombasthenia: Case Report and Literatur Review

Bayraktaroglu T., Colak N., Nalcaci M., Yenerel M. N.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.116, sa.9, ss.549-553, 2008 (SCI-Expanded) identifier identifier identifier

51. A case applied with decompensated heart failure findings diagnosed as primary effusion lymphoma

Yildirim N. D., Bicakci E., Elverdi T., Yenerel M. N., Kucukkaya R. D., Dogan O., et al.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI , cilt.25, sa.2, ss.152-155, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

52. A case of paroxysmal nocturnal hemoglobinuria presenting with intra-abdominal bleeding due to splenic rupture, developing renal infarct

Uzun S., Alpay N., Öztürk G., Saka B., Yenerel M. N., Erten N., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY , sa.3, ss.248-253, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

53. Primary pulmonary lymphoma: A report of two cases

Yildirim N. D., Elverdi T., Bicakci E., Gokcen G., Yenerel M. N., Kucukkaya R. D., et al.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI , cilt.25, sa.1, ss.82-86, 2008 (SCI-Expanded) identifier identifier identifier

54. Atypical M-protein localization in protein electrophoresis in a patient with multiple myeloma

Yildirim N. D., Ayer M., Hatipoglu E., Kucukkaya R. D., Yenerel M. N., Nalcaci M.
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI , cilt.25, sa.1, ss.56-59, 2008 (SCI-Expanded) identifier identifier

55. Leukocytoclastic vasculitis due to thalidomide in multiple myeloma

Yildirim N. D., Ayer M., Kuecuekkaya R. D., Alpay N., Mete O., Yenerel M. N., et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.37, sa.9, ss.704-707, 2007 (SCI-Expanded) identifier identifier identifier

56. Haemophagocytosis in a patient with Crimean-Congo haemorrhagic fever

Cagatay A., Kapmaz M., Karadeniz A., Basaran S., Yenerel M. N., Yavuz S., et al.
JOURNAL OF MEDICAL MICROBIOLOGY , cilt.56, sa.8, ss.1126-1128, 2007 (SCI-Expanded) identifier identifier identifier

57. CLINICAL FOLLOW-UP AND TREATMENT RESPONSE OF THE 162 PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA

YENEREL M. N., Atamer T., Ayer M., Yildirim N. D., Kucukkaya R. D., Yavuz A. S., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.70, sa.1, ss.6-10, 2007 (ESCI) identifier

58. Expression of adducin genes during erythropoiesis: A novel erythroid promoter for ADD2

Yenerel M. N., Sundell I., Weese J., Bulger M., Gilligan D.
EXPERIMENTAL HEMATOLOGY , cilt.33, sa.7, ss.758-766, 2005 (SCI-Expanded) identifier identifier identifier

59. Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years

Kalayoglu-Besisik S., Yenerel M. N., Caliskan Y., Ozturk S., Besisik F., Sargin D.
TRANSPLANTATION PROCEEDINGS , cilt.37, sa.5, ss.2285-2289, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

60. Diffuse alveolar hemorrhage associated with thrombotic thrombocytopenic purpura after allogeneic bone marrow transplantation

Kalayoglu Besisik S., Yenerel M. N., Diz Küçükkaya R., Çalişkan Y., Sargin D.
Turkish Journal of Haematology , cilt.21, sa.4, ss.197-201, 2004 (SCI-Expanded) identifier identifier

61. The in vitro effect of interferon-alpha 2a on CD95 expression of T cells in hepatitis B

Karan M., Ozturk S., Yenerel M. N., Erten N., Cefle K., Palanduz S., et al.
HEPATO-GASTROENTEROLOGY , cilt.50, sa.54, ss.2031-2034, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

62. The outcome of large B-cell lymphoma evolving in a hematopoietic stem cell transplant patient during treatment of chronic graft-versus-host disease

Kalayoǧlu K., Kocaman O., Erer B., Yenerel M. N., Doǧan Ö., Sargin D.
Turkish Journal of Haematology , cilt.20, sa.3, ss.171-174, 2003 (SCI-Expanded) identifier

63. Outcome after hyperbaric oxygen treatment for cyclophosphamide-induced refractory hemorrhagic cystitis.

Kalayoglu-Besisik S., Abdul-Rahman I., Erer B., Yenerel M. N., Oguz F., Tunc M., et al.
The Journal of urology , cilt.170, sa.3, ss.922, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

64. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study

Yeneral M. N., Atamer T., YAVUZ A. F., Kucukkaya R., BEŞIŞIK S., Aktan M., et al.
ANNALS OF HEMATOLOGY , cilt.81, sa.9, ss.498-503, 2002 (SCI-Expanded) identifier identifier identifier

65. Favorable outcome of isolated membranous nephropathy in an allogeneic stem cell recipient

Kalayoglu-Besisik S., Yurci A., Yenerel M. N., KAZANCIOĞLU R., Turkmen A., Kilicarslan Y., et al.
BONE MARROW TRANSPLANTATION , cilt.29, 2002 (SCI-Expanded) identifier

66. Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome

Diz-Kucukkaya R., Demir K., Yenerel M. N., Nalcaci M., Kaymakoglu S., Inanc M.
HAEMATOLOGIA , cilt.32, sa.1, ss.73-77, 2002 (SCI-Expanded) identifier identifier identifier

67. HHV-8 is not ubiquitus in Turkish multiple myeloma patients as determined by nested-PCR and also serological analysis.

Torun A., Kalayoglu-Besisik S., Ozkan E., Basaran P., Yenerel M. N., Karan M., et al.
BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded) identifier

68. Thrombotic complications in essential thrombocythemia.

Atamer T., Yenerel M. N., Yavuz A., Kucukkaya R., Besisik S., Aktan M., et al.
BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded) identifier

69. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: A single center study.

Yenerel M. N., Atamer T., Yavuz A., Kucukkaya R., Besisik S., Aktan M., et al.
BLOOD , cilt.98, sa.11, 2001 (SCI-Expanded) identifier

70. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study

Diz-Kucukkaya R., hacıhanefioğlu a., Yenerel M. N., TURGUT M., Keskin H., Nalcaci M., et al.
BLOOD , cilt.98, sa.6, ss.1760-1764, 2001 (SCI-Expanded) identifier identifier identifier

71. Paroxysmal nocturnal hemoglobinuria clone in patients with myelodysplastic syndrome

Yenerel M. N., Diz-Kucukkaya R., Besisik S., Aktan M., Nalcaci M., Dincol G., et al.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.68, sa.1, ss.64-65, 2001 (SCI-Expanded) identifier identifier identifier

72. CD15-expressing phagocytic plasma cells in a patient with multiple myeloma

KUCUKKAYA R., HACIHANEFIOGLU A., YENEREL M. N., TURGUT M., NALCACI M., KESKIN H., et al.
BLOOD , cilt.97, sa.2, ss.581-583, 2001 (SCI-Expanded) identifier identifier identifier

73. Chimerism status in allo-pbsct versus allo-BMT: single center results

Uzbek U., Kalayoglu-Besisik S., Aydin M., Yenerel M. N., Aktan M., Budak T., et al.
Blood , cilt.96, 2000 (SCI-Expanded) identifier

74. Chimerism status in allo-PBSCT versus allo-BMT: Single center results.

Özbek U., Kalayoglu-Besısık S., Aydin M., Yenerel M. N., Aktan H., Budak T., et al.
BLOOD , cilt.96, sa.11, 2000 (SCI-Expanded) identifier

75. The influence of flow cytometric gating strategy and cell preparation procedures on CD34(+) cell quantification

Yenerel M. N., Budak-Alpdogan T., Kalayoglu-Besisik S., Yanasik M., Sargin D.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH , cilt.9, sa.1, ss.11-12, 2000 (SCI-Expanded) identifier identifier identifier

76. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis

Yenerel M. N., HATEMİ A. İ., Keskin H.
HAEMATOLOGICA , cilt.84, sa.8, ss.766-767, 1999 (SCI-Expanded) identifier identifier identifier

77. Bernard-Soulier syndrome caused by a novel insertional mutation in the glycoprotein IB alpha gene

Nagel T., Kim H., Yenerel M. N., Pekcelen Y., Mahley R., Afshar-Kharghan V., et al.
THROMBOSIS AND HAEMOSTASIS , ss.690, 1999 (SCI-Expanded) identifier

78. Iron deficiency anemia of unknown etiology and/or resistance to the treatment: The sole manifestation of adult celiac disease (CD) [5]

YENEREL M. N., Kalayoglu-Besisik S.
American Journal of Hematology , cilt.61, sa.2, ss.156-157, 1999 (SCI-Expanded) identifier identifier

79. Iron deficiency anemia of unknown etiology and or resistance to the treatment: The sole manifestation of adult celiac disease (CD)

Yenerel M. N., Kalayoglu-Besisik S.
AMERICAN JOURNAL OF HEMATOLOGY , cilt.61, sa.2, ss.156-157, 1999 (SCI-Expanded) identifier

80. The source of stem cells (BMT versus PBSCT) in adult allogeneic transplantation does not only predict the incidence of chronic GVHD but also the outcome of the transplant.

Besisik S., Budak T., Yenerel M. N., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , cilt.23, 1999 (SCI-Expanded) identifier

81. Bernard-Soulier syndrome: Differential platelet glycoprotein Ib-IX-V expression in five distinct Turkish kindreds.

Nagel T., Yenerel M. N., Diz-Kucukkaya R., Pekcelen Y., Hicsonmez G., Kim H., et al.
BLOOD , cilt.92, sa.10, 1998 (SCI-Expanded) identifier

82. High risk of chronic graft-versus-host disease in unmanipulated allogeneic peripheral blood stem cell transplantation

Kalayoglu-Besisik S., Budak-Alpdogan T., Yenerel M. N., Sargin D., Tangun Y.
BLOOD , cilt.92, sa.8, ss.2973-2975, 1998 (SCI-Expanded) identifier identifier identifier

83. Adult T cell acute lymphoblastic leukemia: Clinical parameters and outcome

Yenerel M. N., Nalcaci M., Aktan M., Yavuz S., Keskin H., Sargin D., et al.
BRITISH JOURNAL OF HAEMATOLOGY , cilt.102, sa.1, ss.229, 1998 (SCI-Expanded) identifier

84. Concomitant chronic lymphocytic leukemia and acute myeloid leukemia diagnosed by two color flow cytometric analysis

Yenerel M. N., Hatemi I., Keskin H.
BRITISH JOURNAL OF HAEMATOLOGY , cilt.102, sa.1, ss.201, 1998 (SCI-Expanded) identifier

85. Clinical and hematological study of 11 patients with paroxysmal nocturnal hemoglobinuria

Yenerel M. N., Nalcaca M., Atamer T., Pekcelon Y.
BRITISH JOURNAL OF HAEMATOLOGY , cilt.102, sa.1, ss.307, 1998 (SCI-Expanded) identifier

86. Thrombocytopenia in allogeneic peripheral blood stem cell transplantation (allo-PBSCT) donors.

Besisik S., Alpdogan T., Yenerel M. N., Altay S., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , cilt.21, 1998 (SCI-Expanded) identifier

87. Allogeneic peripheral blood stem cell transplantation (allo-PBSCT) versus allogeneic bone marrow transplantation (allo-BMT): Rapid engraftment but increased morbidity due to GVHD

Besisik S., Yenerel M. N., Alpdogan T., Yavuz A., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , cilt.21, 1998 (SCI-Expanded) identifier

88. Autonomic dysfunction in vitamin B12 deficiency: A heart rate variability study

Sozen A., Demirel S., Akkaya V., Kudat H., Tukek T., Yeneral M. N., et al.
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM , cilt.71, sa.1, ss.25-27, 1998 (SCI-Expanded) identifier identifier identifier

89. Graft versus myeloma effect augmented by donor leukocyte infusions (DLI) following an incomplete response to allogeneic blood stem cell transplantation (ALLO-BSCT): A case report.

Besisik S., Yenerel M. N., Alpdogan T., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , cilt.21, 1998 (SCI-Expanded) identifier

90. The value of reticulocyte maturity index (RMI) as a predictor of engraftment in allogeneic peripheral blood stem cell transplantation (allo-PBSCT)

Yenerel M. N., Besisik S., Alpdogan T., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , cilt.21, 1998 (SCI-Expanded) identifier

91. The influence of flow cytometric (FC) gating strategy and cell preparation procedures on CD34+ cell enumeration.

Budak-Alpdogan T., Yenerel M. N., Besisik-Kalayoglu S., Yanasik M., Sargin D., Tangun Y.
BONE MARROW TRANSPLANTATION , cilt.21, 1998 (SCI-Expanded) identifier

92. Incidence and severity of GVHD in allogeneic peripheral blood stem cell transplantation (ALLO-PBSCT). Analysis of 21 patients.

Besisik S., Yenerel M. N., Alpdogan T., Sargin D., Tangun Y.
BLOOD , cilt.90, sa.10, ss.4495, 1997 (SCI-Expanded) identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 53

1. Multipl Miyelom'da Genetik Karmaşa: Optik Genom Haritalamanın Yeri

BAYRAK TOKAÇ A. G., ERDEM S., ADAY A., MUTLU M. B., GÜNEY D. K., MASTANZADE M., et al.
12. Hematolojik Onkoloji Kongresi, KKTC, Türkiye, 02 Ekim 2025, ss.134-137, (Özet Bildiri)

2. Kronik Lenfositik Lösemide Optik Genom Haritalamanın FISH Analizine Tamamlayıcı Rolü: Tek Merkez Pilot Çalışma

ERDEM S., BAYRAK TOKAÇ A. G., ADAY A., KARACA D., MUTLU M. B., ÇEFLE K., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 28 Ekim - 02 Kasım 2025, ss.121-122, (Özet Bildiri)

3. Bir Taşla İki Kuş: Akalabrutinib ile KLL ve Anjiyoödem Kontrolü

SARAÇ Z., ERDEM S., KORUK K., MASTANZADE M., HÖRMET İĞDE M., YEĞİT O. O., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 28 Ekim 2025, ss.337-338, (Özet Bildiri)

4. Yeni Tanı Multipl Miyelomda Tromboz Riskinin Öngörülmesi: 589 Hastalık Gerçek Yaşam Deneyimi

MASTANZADE M., HASANZADE U., İNAN N. Y., TAHA F. J., EMEL P., ERDEM S., et al.
51. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 28 Ekim 2025, ss.191, (Özet Bildiri)

5. Multipl Myelomda lenalidomidin beklenmeyen yüzü: Lökositoklastik vaskülit

AKIN A., KILIÇ İ., KORUK K., ERDEM S., YENEREL M. N.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri İnteraktif Güncelleştirme 2025, Sapanca/Sakarya, Türkiye, 10 Nisan 2025, ss.58, (Özet Bildiri)

6. The Silent Threat of Secondary Malignancies in Multiple Myeloma Patients: A Cohort Study from Turkey in the Era of New Drugs

Mastanzade M., Taha F. J., Hasanzade U., İnan N. Y., Zeynallı B., Ören Çelik M. M., et al.
The 11th World Congress on CONTROVERSIES IN MULTIPLE MYELOMA (COMy), Paris, Fransa, 15 Mayıs 2025, (Özet Bildiri)

7. A Single-Center Real-Life Experience with First-Line Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (DARA-VCD) in AL Amyloidosis

MASTANZADE M., ÖREN ÇELİK M. M., ERDEM S., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Hematoloji Uzmanlık Derneği 18. Ulusal Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2024, cilt.46, ss.26-27, (Özet Bildiri)

8. Optical Genome Mapping in Newly Diagnosed Chronic Lymphocytic Leukemia

ERDEM S., BAYRAK TOKAÇ A. G., ADAY A., KARACA D., ÖZTÜRK Ş., ÇEFLE K., et al.
66th ASH Annual Meeting and Exposition, San Diego, CA, Amerika Birleşik Devletleri, 7 - 10 Aralık 2024, ss.6758, (Özet Bildiri)

9. Akut Miyeloid Lösemide İzositrat Dehidrogenaz 1 (IDH1) Gen Mutasyonu Sıklığı ve Klinik: Tek Merkez Deneyimi

ÇATMA Y., ERDEM S., ADAY A., MASTANZADE M., ÖZBALAK M. M., YÖNAL HİNDİLERDEN İ., et al.
50. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 29 Ekim 2024, ss.228, (Özet Bildiri)

10. Multipl miyelomda kemik iliği fibrozisinin ekstramedüller hastalık ile ilişkisi

Konyaoğlu H., Altay A. Y., Işık E. G., Oluk B., Taghiyeva N., Sakcı E., et al.
25. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 8 - 12 Kasım 2023, ss.77-78, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

11. The relationship of bone marrow fibrosis with extramedullary disease in multiple myeloma

Konyaoğlu H., Altay A. Y., Işık E. G., Oluk B., Taghiyeva N., Sakcı E., et al.
28th Congress of the European Hematology Association (EHA 2023), Frankfurt, Almanya, 08 Haziran 2023, ss.1776, (Özet Bildiri)

12. The role of 18F-FDG PET/CT Scan in adult langerhans cell histiocytosis: A single center experience

ERDEM S., ÇETİN O., KIRAN M. Y., IŞIK E. G., BEYAZ BELKAYA Ş., YEGEN G., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Türkiye, 5 - 07 Mayıs 2023, ss.40-41, (Özet Bildiri)

13. Insight into hypereosinophilia from the hematology clinic; A single-center experience

OLUK B., TAGHİYEVA N., SAKCI E., ERDEM S., YÖNAL HİNDİLERDEN İ., YENEREL M. N., et al.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Türkiye, 05 Mayıs 2023, ss.64, (Özet Bildiri)

14. Covid vaccination associated acquired thrombotic thrombocytopenic purpura

SİLAY R., TAGHİYEVA N., ERDEM S., YENEREL M. N.
Soho 2023 Türkiye Tenth Annual Meeting, İstanbul, Türkiye, 05 Mayıs 2023, ss.52, (Özet Bildiri)

15. GRAVES HASTALIĞI VE DİFFÜZ BÜYÜK B HÜCRELİ LENFOMA BİRLİKTELİĞİ

Kıkılı C. İ., SARIBEYLİLER G., ALTINKAYNAK M., ERDEM S., KUBAT ÜZÜM A., YENEREL M. N.
24. Ulusal İç Hastalıkları Kongresi, Antalya, Türkiye, 19 - 23 Ekim 2022, ss.112-113, (Tam Metin Bildiri)

16. Multipl miyelom dışı plazma hücre hastalıklarında kök hücre desteği ile yüksek doz kemoterapi deneyimi

TİRYAKİ T. O., YÖNAL HİNDİLERDEN İ., ERDEM S., MASTANZADE M., ÖZBALAK M. M., OLUK B., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.196-197, (Özet Bildiri)

17. Kronik lenfositer lösemi olgularının tanı sırasındaki T lenfosit alt gruplarının prognoz üzerine etkisi

SEYİTHANOĞLU D., NAZLIGÜL SERT E., ERDEM S., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.145-146, (Özet Bildiri)

18. Kronik lenfositik lösemi tanısında FCRL gen ailesi ekspresyon seviyelerinin araştırılması

ÇOŞKUNPINAR E. M., GÜNDÜZ K., ERDEM S., YENEREL M. N.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.149-150, (Özet Bildiri)

19. Kronik lenfositik lösemi hastalarında tanısal parametrelerin değerlendirilmesi

GÜNDÜZ K., ÇOŞKUNPINAR E. M., ERDEM S., YENEREL M. N.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.293, (Özet Bildiri)

20. Büyük granüllü lenfosit artışı olan olguların tanısında immünfenotiplemenin rolü: Tek merkez deneyimi

NAZLIGÜL SERT E., TİRYAKİ T. O., ÖZBALAK M. M., MASTANZADE M., ÖZLÜK D. Ö., ERDEM S., et al.
48. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 01 Kasım 2022, ss.199-200, (Özet Bildiri)

21. WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

ERDEM S., MASTANZADE M., ÖZBALAK M. M., KUBİLAY D. Ö., TİRYAKİ T. O., OLUK B., et al.
XIIth Eurasian Hematology-Oncology Congress, İSTANBUL (Hibrit Kongre), Türkiye, 10 Kasım 2021, cilt.43, ss.96, (Özet Bildiri)

22. Yeni tanı DBBHL’de biyobenzer rituksimab (Redditux) içeren R-CHOP rejimi sonuçları: Tek merkez gerçek yaşam deneyimi

ÖZBALAK M. M., MASTANZADE M., KUBİLAY D. Ö., TİRYAKİ T. O., ERDEM S., Pınar Özbalak E., et al.
47. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 04 Kasım 2021, (Tam Metin Bildiri)

23. R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Özbalak M. M., Mastanzade M., Özlük Ö., Tiryaki T. O., Erdem S., Özbalak E. P., et al.
63rd ASH Annual Meeting and Exposition, Georgia, Amerika Birleşik Devletleri, 11 - 14 Aralık 2021, ss.4585, (Özet Bildiri)

24. A raman tweezer study with single red blood cells for the diagnosis of paroxysmal nocturnal hemoglobinuria

Parlatan S., Parlatan U., Soysal K. B., Mastanzade M., Ozbalak M. M., Yenerel M. N., et al.
Optical Molecular Probes, Imaging and Drug Delivery, OMP 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, Amerika Birleşik Devletleri, 12 - 16 Nisan 2021, (Tam Metin Bildiri) identifier

25. Dual-Beam optical Manipulation of Red blood cells for the investigation of paroxysmal nocturnal hemoglobinuria

Parlatan U., Soysal K. B., Parlatan S., Mastanzade M., Ozbalak M. M., Yenerel M. N., et al.
Optical Manipulation and Its Applications, OMA 2021 - Part of Biophotonics Congress: Optics in the Life Sciences 2021, Virtual, Online, Amerika Birleşik Devletleri, 12 - 16 Nisan 2021, (Tam Metin Bildiri) identifier

26. Steroide duyarlı kronik anemisi ve osteosklerozu olan erişkin olguda moleküler tanının klinik izleme etkisi

Sharifi S., Kalaycı T., Kaya M., SUER İ., ÖZTÜRK Ş., ÇEFLE K., et al.
14. Ulusal Tıbbi Genetik Kongresi (Uluslararası katılımlı), Türkiye, 20 - 23 Kasım 2020, ss.37, (Özet Bildiri)

27. Prognostic value of pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratio in diffuse large B-cell lymphoma: a single-center experience

Dağcı G., Mastanzade M., Özbalak M. M., Kubilay D. Ö., Tiryaki T. O., Yönal Hindilerden İ., et al.
XIth Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 21 - 24 Ekim 2020, sa.42, ss.48-49, (Özet Bildiri)

28. MİKROANJİYOPATİK HEMOLİTİK ANEMİNİN GEÇ GELİŞTİĞİ BİR ATİPİK HEMOLİTİK ÜREMİK SENDROM VAKASI

Gülseren Ü. A., DENİZ R., ALTINKAYNAK M., YAZICI H., YENEREL M., ERTEN S. N., et al.
İstanbul Tıp Fakültesi Geleneksel İç Hastalıkları Günleri - İnteraktif Güncelleştirme 2020, Sakarya, Türkiye, 12 Mart 2020, ss.165, (Tam Metin Bildiri)

29. Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

KEKLİK KARADAĞ F., Yenerel M. N., Mehmet Y., Teke H. U., Ozkocaman V., Tuglular T., et al.
61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134, (Özet Bildiri) identifier

30. A retrospective analysis of peripheral T-cell lymphoma patients: single-center 'real-life' experience

Ozbalak M. M., Besisik S., Mastanzade M., Ozluk O., Ozmen A., Hindilerden I. Y., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 8 - 11 Ekim 2019, cilt.85, (Özet Bildiri) identifier

31. The efficacy of reuse therapeutic plasma exchange in relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a single-center experience of 130 cases

Mastanzade M., Besisik S., Dadin S. A., Aktan M., Hindilerden I. Y., Yenerel M. N., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Türkiye, 8 - 11 Ekim 2019, cilt.85, (Özet Bildiri) identifier

32. The Importance of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Cohort Study

Yenerel M. N., Erdem S., Mastanzade M., Nalcaci M.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri) identifier

33. Akut Myeloid Lösemi ve 3q Kromozomal Yeniden Düzenlenmeleri

Bagatir G., Kaya M., Dön B., SUER İ., NALÇACI M., YENEREL M. N., et al.
3. Ulusal Uygulamalı Biyolojik Bilimler Kongresi (UBBK), Eskişehir, Türkiye, 3 - 05 Mayıs 2018, cilt.1, ss.35, (Özet Bildiri)

34. The Whole Exome Analysis and Clinical Relevance in Patients with Atypical Hemolytic Uremic Syndrome

Yenerel M. N., Caliskan Y., Yildiz A., Karadeniz S., Turkmen A., Kayacan M. S., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, Amerika Birleşik Devletleri, 9 - 12 Aralık 2017, cilt.130, (Özet Bildiri) identifier

35. RNA sequencing and in silico analysis of Myeloma cells in multiple myeloma patients

Sarıman M., SIRMA EKMEKCİ S., ABACI N., ÇAKİRİS A., PAÇAL F., ÜSTEK D., et al.
XV.Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye- Muğla, Türkiye, 26 - 29 Ekim 2017, ss.108, (Özet Bildiri)

36. Yine yeniden Hodgkin lenfoma olguları: Nüks mü ikincil kanser mi?

Erdem S., Demir N., Özkan S. G., Yenerel M. N., Yeğen G., Doğan İ. Ö., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 1 - 04 Kasım 2017, ss.156, (Özet Bildiri) Sürdürülebilir Kalkınma

37. Multiple Myeloma hastalarının Myeloma hücrelerinde RNA dizileme ve in-silico analizler.

Sarıman M., Sırma Ekmekci S., Abacı N., Çakiris A., Perçin Paçal F., Üstek D., et al.
XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Fethiye, Muğla, Türkiye, 26 Ekim 2017, (Yayınlanmadı)

38. Multiple Myeloma hastalarının Myeloma hücrelerinde RNA dizileme ve insilico analizler.

Sarıman M., Sırma Ekmekci S., Abacı N., Çakiris A., Paçal F., Üstek D., et al.
XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi , Muğla, Türkiye, 26 - 29 Ekim 2017, ss.108-109, (Özet Bildiri)

39. Investigation of gene expression of myeloma cells in bone marrow of multiple myeloma patients by transcriptome analysis

Sarıman M., SIRMA EKMEKCİ S., ABACI N., ÇAKİRİS A., PAÇAL F., ÜSTEK D., et al.
ESHG 2016, Barcelona, İspanya, 21 - 24 Mayıs 2016, ss.153, (Tam Metin Bildiri)

40. USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY

Cekdemir D., Ozdemirkiran F., Guvenc S., Eser A., Ozkocaman V., Sahin H. H., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141, (Özet Bildiri) identifier

41. Patients with Paroxysmal Nocturnal Hemoglobinuria and Hemolysis Demonstrate More Frequent Disease-Related Features Than Those without Hemolysis, but Similar Proportions Experience Thromboembolism

Yenerel M. N., Muus P., Wilson A., Szer J.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri) identifier

42. Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria

Erkek E. T., Nazligul E., Nalcaci M., Aktan M., Yenerel M. N.
57th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 5 - 08 Aralık 2015, cilt.126, (Özet Bildiri) identifier

43. ACI LDE ZOR VAKALAR ZOR KARARLAR

KÖSE M., GÜLER K., YENEREL M. N., TÜKEK T.
17. Ulusal İç Hastalıkları Kongresi, Türkiye, 14 - 18 Ekim 2015

44. Hasta ortada kalmasın Multidisipliner yaklaşım

TÜKEK T., TANAKOL R., KAYMAKOĞLU S., YENEREL M. N., KÖSE M.
"Geleneksel İç Hastalıkları Günleri-İnteraktif Güncelleştirme - 2016", Türkiye, 11 - 13 Mart 2015

45. VAKALARLA ACI LDE KANAMALI HASTAYA YAKLAS IM

TÜKEK T., YENEREL M. N., KÖSE M.
16. Ulusal İç Hastalıkları Kongresi, Türkiye, 15 - 19 Ekim 2014

46. ZBTB7A AND BCL6 GENES ARE NOT EXPRESSED IN CLL

Isin M., Yenerel M. N., Aktan M., Buyru N., Dalay N.
38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Almanya, 3 - 08 Eylül 2010, cilt.31, (Özet Bildiri) identifier

47. The evaluation of the genomic instability by micronucleus and sister chromatid exchange in myelodysplastic syndrome

Nazligul E., Palanduz P., Ozturk O., Bayrak A., Ucur A., Bagatir G., et al.
7th European Cytogenetics Conference, Stockholm, İsveç, 4 - 07 Temmuz 2009, cilt.17, ss.137-138, (Özet Bildiri) identifier

48. Kronik Lenfositik Lösemili Hastalarda p53 P14ARF ve HDM2 Gen İfade Düzeyleri

IŞIN M., YENEREL M. N., AKTAN M., BUYRU A. N., DALAY N.
XVIII. Ulusal Kanser Kongresi, Antalya, Antalya, Türkiye, 21 - 26 Nisan 2009, ss.194, (Tam Metin Bildiri) Creative Commons License

49. Does previous interferon use have negative effect on imatinib response in chronic myeloid leukemia (CML)? A single center study.

Yenerel M. N., Diz-Kucukkaya R., Demirel N., Ayer M., Yavuz S., Besisik S., et al.
48th Annual Meeting of the American-Society-of-Hematology, Florida, Amerika Birleşik Devletleri, 9 - 12 Aralık 2006, cilt.108, (Özet Bildiri) identifier

50. The association of HLA class I antigens and class II alleles with multiple myeloma in Turkey.

Kalayoglu-Besisik S., Erer B., Savran-Oguz F., Yucel S., Erten N., Yenerel M. N., et al.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102, (Özet Bildiri) identifier

51. beta-adducin gene expression is suppressed during megakaryopoiesis.

Sundell-Ranby B., Yenerel M. N., Shim M., Reems J., Gilligan D.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102, (Özet Bildiri) identifier

52. Differential expression of adducin mRNAs during erythropoiesis.

Yenerel M. N., Sundell B., Gilligan D.
44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 6 - 10 Aralık 2002, cilt.100, (Özet Bildiri) identifier

53. Myeloid/Natural Killer Cell Acute Leukemia: A Case Report

Turgut M., GELİNCİK A., YENEREL M. N., Köroğlu G., AKTAN M., Pekçelen Y.
5th Annual Meeting of The European Haematology Association, Birmington, Birleşik Krallık, 25 - 28 Haziran 2000, ss.106, (Tam Metin Bildiri)
Metrikler

Yayın

145

Yayın (WoS)

98

Yayın (Scopus)

86

Atıf (WoS)

454

H-İndeks (WoS)

12

Atıf (Scopus)

912

H-İndeks (Scopus)

12

Atıf (Scholar)

4

H-İndeks (Scholar)

1

Proje

2

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları